200,000+ products from a single source!
sales@angenechem.com
31645-39-3 | Phosphorodiamidic acid, N,N'-bis(2-chloroethyl)-
CAS No: 31645-39-3 Catalog No: AG000ZJN MDL No:MFCD01705455
Product Description
Catalog Number:
AG000ZJN
Chemical Name:
Phosphorodiamidic acid, N,N'-bis(2-chloroethyl)-
CAS Number:
31645-39-3
Molecular Formula:
C4H11Cl2N2O2P
Molecular Weight:
221.0221
MDL Number:
MFCD01705455
IUPAC Name:
bis(2-chloroethylamino)phosphinic acid
InChI:
InChI=1S/C4H11Cl2N2O2P/c5-1-3-7-11(9,10)8-4-2-6/h1-4H2,(H3,7,8,9,10)
InChI Key:
BKCJZNIZRWYHBN-UHFFFAOYSA-N
SMILES:
ClCCNP(=O)(NCCCl)O
UNII:
6A4U6NN813
NSC Number:
297900
Properties
Complexity:
134
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
219.994g/mol
Formal Charge:
0
Heavy Atom Count:
11
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
3
Isotope Atom Count:
0
Molecular Weight:
221.018g/mol
Monoisotopic Mass:
219.994g/mol
Rotatable Bond Count:
6
Topological Polar Surface Area:
61.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.4
Literature
| Title | Journal |
|---|---|
| Pharmacokinetics of TH-302: a hypoxically activated prodrug of bromo-isophosphoramide mustard in mice, rats, dogs and monkeys. | Cancer chemotherapy and pharmacology 20120301 |
| Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin. | Anti-cancer drugs 20120201 |
| The effect of N-acetylcysteine on the antitumor activity of ifosfamide. | Canadian journal of physiology and pharmacology 20110501 |
| Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells. | Kidney international 20061101 |
| [Identification of glufosfamide metabolites in rats]. | Yao xue xue bao = Acta pharmaceutica Sinica 20060601 |
| Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide. | Cancer chemotherapy and pharmacology 20050201 |
| 1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustards. | Chemical research in toxicology 20040901 |
| Phosphate prodrugs of isophosphoramide mustard. | Acta poloniae pharmaceutica 20030101 |
| Isophosphoramide mustard analogues as prodrugs for anticancer gene-directed enzyme-prodrug therapy (GDEPT). | Acta biochimica Polonica 20020101 |
| Mechanisms of resistance against cyclophosphamide and ifosfamide: can they be overcome without sacrificing selectivity? | Cancer treatment and research 20020101 |
| Identification of new aqueous chemical degradation products of isophosphoramide mustard. | Journal of pharmaceutical and biomedical analysis 20010601 |
| Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma. | Lancet (London, England) 19800927 |
Related Products
© 2019 Angene International Limited. All rights Reserved.